Herpes simplex virus type 2 in the united states, 1976 to 1994.
Background Herpes simplex virus type 2 (HSV-2) infection is usually transmitted sexually and can cause recurrent, painful genital ulcers.
In neonates the infection is potentially lethal.
We investigated the seroprevalence and correlates of HSV-2 infection in the United States and identified changes in HSV-2 seroprevalence since the late 1970s.
Methods Serum samples and questionnaire data were collected during the National Health and Nutrition Examination Surveys (NHANES) II (1976 to 1980) and III (1988 to 1994).
HSV-2 antibody was assessed with an immunodot assay specific for glycoprotein gG-2 of HSV-2.
Results From 1988 to 1994, the seroprevalence of HSV-2 in persons 12 years of age or older in the United States was 21.9 percent (95 percent confidence interval, 20.2 to 23.6 percent), corresponding to 45 million infected people in the noninstitutionalized civilian population.
The seroprevalence was higher among women (25.6 percent) than men (17.8 percent) and higher among blacks (45.9 percent) than whites (17.6 percent).
Less than 10 percent of all those who were seropositive reported a history of genital herpes infection.
In a multivariate model, the independent predictors of HSV-2 seropositivity were female sex, black race or Mexican-American ethnic background, older age, less education, poverty, cocaine use, and a greater lifetime number of sexual partners. (...)
Mots-clés Pascal : Herpès, Virose, Infection, Maladie sexuellement transmissible, Enquête sur terrain, Méthode immunoblotting, Prévalence, Facteur prédictif, Etude longitudinale, Evaluation, Homme, Etats Unis, Amérique du Nord, Amérique, Appareil génital pathologie, Traitement instrumental, Herpes simplex virus type 2(HSV-2)
Mots-clés Pascal anglais : Herpes, Viral disease, Infection, Sexually transmitted disease, Field inquiry, Immunoblotting assay, Prevalence, Predictive factor, Follow up study, Evaluation, Human, United States, North America, America, Genital diseases, Instrumentation therapy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0542942
Code Inist : 002B05F06. Création : 24/03/1998.